Fort Sheridan Advisors LLC Merck & Co., Inc. Transaction History

Fort Sheridan Advisors LLC

$672 Million
Q4 2024

A detailed history of Fort Sheridan Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 98,259 shares of MRK stock, worth $8.78 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

98,259

Previous 98,434 0.18%

Holding current value

$8.78 Million

Previous $11.2 Million 12.56%

% of portfolio

1.45%

Previous 1.72%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$96.31 - $114.76 $16,854 - $20,083	-175 Reduced 0.18%	98,259 $9.77 Million
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $30,899 - $35,853	-278 Reduced 0.28%	98,434 $11.2 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $966,259 - $1.04 Million	7,805 Added 8.59%	98,712 $12.2 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $345,155 - $402,183	3,048 Added 3.47%	90,907 $12 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $341,382 - $379,118	3,316 Added 3.92%	87,859 $9.05 Million
Q2 2023 Aug 01, 2023	BUY	$108.61 - $118.38 $453,663 - $494,473	4,177 Added 5.2%	84,543 $9.76 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $2.03 Million - $2.26 Million	19,697 Added 32.47%	80,366 $8.55 Million
Q4 2022 Feb 15, 2023	SELL	$87.44 - $112.11 $253,313 - $324,782	-2,897 Reduced 4.56%	60,669 $6.73 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $34,572 - $38,838	409 Added 0.65%	63,566 $5.47 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $647,130 - $733,554	7,751 Added 13.99%	63,157 $5.76 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $197,888 - $221,820	2,692 Added 5.11%	55,406 $4.55 Million
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $77,773 - $97,421	-1,076 Reduced 2.0%	52,714 $4.04 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $100,710 - $110,756	1,405 Added 2.68%	53,790 $4.04 Million
Q2 2021 Aug 17, 2021	BUY	$70.31 - $77.77 $592,010 - $654,823	8,420 Added 19.15%	52,385 $4.07 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $417,085 - $491,283	6,057 Added 15.98%	43,965 $3.39 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $31,578 - $35,046	440 Added 1.17%	37,908 $3.1 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $2,927 - $3,318	40 Added 0.11%	37,468 $3.11 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $84,644 - $96,316	1,202 Added 3.32%	37,428 $2.89 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $184,060 - $255,117	2,905 Added 8.72%	36,226 $2.79 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $69,666 - $78,610	898 Added 2.77%	33,321 $3.03 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $23,584 - $25,708	310 Added 0.97%	32,423 $2.73 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $160,632 - $187,657	2,300 Added 7.71%	32,113 $2.69 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $208,740 - $238,080	3,000 Added 11.19%	29,813 $2.48 Million
Q4 2018 May 13, 2019	BUY	$65.24 - $75.71 $1.75 Million - $2.03 Million	26,813 New	26,813 $2.05 Million

Others Institutions Holding MRK

# of Institutions

3,957

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $226B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Account

Fort Sheridan Advisors LLC Merck & Co., Inc. Transaction History